Clinical Trial

A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age

Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated April 13, 2026 (before its estimated July 31, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study is designed to find out how well the COVID-19 vaccine protects people 50 to 64, who don't have any serious health problems, compared to a group that receives a vaccine that doesn't contain an ingredient to protect against COVID-19 (placebo).
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-12-20.
Status change: Recruiting → Active, Not Recruiting 2026-04-07
Trial Details
NCT Number NCT07300839
Lead Sponsor BioNTech SE
Collaborators: Pfizer
Conditions COVID-19, SARS-COV-2 Infection
Enrollment 5,240 participants
Start Date 2025-12-10
Primary Completion 2026-07-31 (estimated)
Study Completion 2026-07-31 (estimated)
Updated on ClinicalTrials.gov 2026-04-13